Seritage Growth Pptys (SRG) reported $18.2M in revenue for fiscal year 2025, up 3.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Seritage’s core financial mechanic is balance-sheet shrinkage, using investing cash inflows to cut obligations faster than operations replace the lost earnings base.
In the latest year, total liabilities were down to$61.0M and interest expense to$20.3M , so the narrower net loss appears to come chiefly from deleveraging rather than from stronger underlying operations. That distinction matters because revenue was still only$18.2M while operating cash flow stayed negative at-$34.9M , meaning accounting losses improved faster than the business’s ability to fund itself.
This is an asset-heavy company becoming a smaller one: total assets ended at
Even after meaningful cost cutting, overhead still outruns scale: SG&A was
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Seritage Growth Pptys's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Seritage Growth Pptys, and counted as zero in the overall score.
Not available for Seritage Growth Pptys, and counted as zero in the overall score.
Seritage Growth Pptys passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, both operating efficiency signals pass.
Seritage Growth Pptys reported a net loss of $68.2M while operations used $34.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Seritage Growth Pptys generated $18.2M in revenue in fiscal year 2025. This represents an increase of 3.3% from the prior year.
Seritage Growth Pptys reported -$68.2M in net income in fiscal year 2025. This represents an increase of 55.6% from the prior year.
Seritage Growth Pptys earned -$1.30 per diluted share (EPS) in fiscal year 2025. This represents an increase of 53.9% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Seritage Growth Pptys held $48.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Seritage Growth Pptys's ROE was -20.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 17.4 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
SRG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9M | $18.2M+3.3% | $17.6M-15.2% | $20.8M-80.6% | $107.1M-8.3% | $116.7M+0.2% | $116.5M-30.9% | $168.6M-21.5% | $214.8M-10.9% | $241.0M-3.1% | $248.7M |
| SG&A Expenses | $20.5M | $31.9M+6.4% | $30.0M-34.7% | $46.0M-3.5% | $47.6M+13.6% | $41.9M+45.4% | $28.8M-26.3% | $39.2M+12.6% | $34.8M+24.7% | $27.9M+59.7% | $17.5M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$114.6M-276.3% | -$30.4M |
| Interest Expense | $15.7M | $20.3M-18.8% | $25.0M-44.0% | $44.6M-48.6% | $86.7M-19.7% | $108.0M+18.2% | $91.3M-3.4% | $94.5M+5.0% | $90.0M+28.4% | $70.1M+10.3% | $63.6M |
| Income Tax | $75K | $0-100.0% | $1.6M+4068.4% | $38K-91.8% | $466K+137.8% | $196K-22.2% | $252K+28.6% | $196K-38.9% | $321K+18.5% | $271K-46.3% | $505K |
| Net Income | -$54.0M | -$68.2M+55.6% | -$153.5M+0.9% | -$154.9M-109.5% | -$73.9M-162.7% | -$28.1M+73.2% | -$105.0M-76.8% | -$59.4M+19.2% | -$73.5M+0.4% | -$73.8M-43.1% | -$51.6M |
| EPS (Diluted) | — | -$1.30+53.9% | -$2.82+1.1% | -$2.85-79.2% | -$1.59-103.8% | -$0.78+72.8% | -$2.87-62.1% | -$1.77+19.5% | -$2.20-0.5% | -$2.19-33.5% | -$1.64 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SRG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $393.8M-41.9% | $677.8M-30.4% | $973.9M-47.1% | $1.8B-23.7% | $2.4B-8.9% | $2.6B-3.7% | $2.8B-4.4% | $2.9B+3.6% | $2.8B+2.3% | $2.7B |
| Cash & Equivalents | $48.1M-43.6% | $85.2M-36.4% | $134.0M+0.4% | $133.5M+25.2% | $106.6M-25.8% | $143.7M+3.2% | $139.3M-73.9% | $532.9M+120.6% | $241.6M+364.3% | $52.0M |
| Total Liabilities | $61.0M-77.6% | $272.0M-33.8% | $410.7M-63.3% | $1.1B-28.7% | $1.6B-11.1% | $1.8B+3.5% | $1.7B-1.1% | $1.7B+18.6% | $1.5B-23.7% | $1.9B |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1.2B+3.0% | $1.2B |
| Total Equity | $331.4M-18.1% | $404.5M-28.0% | $562.0M-22.0% | $720.5M+4.8% | $687.7M+6.0% | $649.0M-11.3% | $731.4M-6.3% | $780.8M-11.9% | $886.7M+10.2% | $804.6M |
| Retained Earnings | -$1.0B-7.6% | -$958.8M-19.8% | -$800.3M-24.9% | -$640.5M-15.7% | -$553.8M-4.8% | -$528.6M-26.3% | -$418.7M-21.7% | -$344.1M-49.8% | -$229.8M-89.4% | -$121.3M |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.
SRG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$21.0M | -$34.9M+34.8% | -$53.5M-0.9% | -$53.1M+55.0% | -$117.9M+13.3% | -$136.0M-187.4% | -$47.3M+17.9% | -$57.7M-205.0% | $54.9M-7.9% | $59.6M-38.7% | $97.2M |
| Investing Cash Flow | $164.4M | $198.5M+56.4% | $126.9M-82.7% | $732.9M+25.1% | $586.1M+124.8% | $260.7M+508.2% | $42.9M+114.3% | -$299.5M-150.7% | -$119.5M-421.3% | $37.2M+159.6% | -$62.4M |
| Financing Cash Flow | -$160.7M | -$199.0M-58.8% | -$125.3M+81.4% | -$675.1M-54.5% | -$437.0M-171.1% | -$161.2M-1144.1% | $15.4M+142.4% | -$36.4M-120.2% | $180.2M-0.3% | $180.8M+458.1% | -$50.5M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $18.0M-49.6% | $35.7M+4.2% | $34.2M-13.0% | $39.4M |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SRG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -47.5%-35.3pp | -12.2% |
| Net Margin | -374.7% | -871.3% | -745.5% | -69.1%-45.0pp | -24.1%+66.0pp | -90.1%-54.9pp | -35.2%-1.0pp | -34.2%-3.6pp | -30.6%-9.9pp | -20.7% |
| Return on Equity | -20.6%+17.4pp | -38.0%-10.4pp | -27.6%-17.3pp | -10.3%-6.2pp | -4.1%+12.1pp | -16.2%-8.1pp | -8.1%+1.3pp | -9.4%-1.1pp | -8.3%-1.9pp | -6.4% |
| Return on Assets | -17.3%+5.3pp | -22.7%-6.7pp | -15.9%-11.9pp | -4.0%-2.8pp | -1.2%+2.8pp | -4.0%-1.8pp | -2.2%+0.4pp | -2.5%+0.1pp | -2.7%-0.8pp | -1.9% |
| Debt-to-Equity | 0.18-0.5x | 0.67-0.1x | 0.73-0.8x | 1.55-0.7x | 2.28-0.4x | 2.72+0.4x | 2.33+0.1x | 2.21+0.9x | 1.36-0.1x | 1.45 |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Where Seritage Growth Pptys Ranks
Frequently Asked Questions
What is Seritage Growth Pptys's annual revenue?
Seritage Growth Pptys (SRG) reported $18.2M in total revenue for fiscal year 2025. This represents a 3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Seritage Growth Pptys's revenue growing?
Seritage Growth Pptys (SRG) revenue grew by 3.3% year-over-year, from $17.6M to $18.2M in fiscal year 2025.
Is Seritage Growth Pptys profitable?
No, Seritage Growth Pptys (SRG) reported a net income of -$68.2M in fiscal year 2025.
What is Seritage Growth Pptys's return on equity (ROE)?
Seritage Growth Pptys (SRG) has a return on equity of -20.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Seritage Growth Pptys's operating cash flow?
Seritage Growth Pptys (SRG) recorded an outflow of $34.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Seritage Growth Pptys's total assets?
Seritage Growth Pptys (SRG) had $393.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Seritage Growth Pptys's debt-to-equity ratio?
Seritage Growth Pptys (SRG) had a debt-to-equity ratio of 0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Seritage Growth Pptys's return on assets (ROA)?
Seritage Growth Pptys (SRG) had a return on assets of -17.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Seritage Growth Pptys's cash runway?
Based on fiscal year 2025 data, Seritage Growth Pptys (SRG) had $48.1M in cash against an annual operating cash burn of $34.9M. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Seritage Growth Pptys's Piotroski F-Score?
Seritage Growth Pptys (SRG) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Seritage Growth Pptys's earnings high quality?
Seritage Growth Pptys (SRG) reported a net loss of $68.2M while operations used $34.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Seritage Growth Pptys?
Seritage Growth Pptys (SRG) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.